Review article: Nitric oxide from dysbiotic bacterial respiration of nitrate in the pathogenesis and as a target for therapy of ulcerative colitis

Alimentary Pharmacology and Therapeutics

Volumn 27, Issue 7, 2008, Pages 531-541

  Roediger, W E W ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ION CHANNEL; MESALAZINE; METRONIDAZOLE; NITRATE; NITRIC OXIDE; NITRITE; NITROUS OXIDE; PENICILLIN G; PREBIOTIC AGENT; PROBIOTIC AGENT; STEROID; SULFIDE; SYNBIOTIC AGENT; TETRACYCLINE; TOBRAMYCIN;

ANAEROBIC BACTERIUM; CELL DAMAGE; CLINICAL TRIAL; COLON FLORA; COMBINATION CHEMOTHERAPY; DENITRIFICATION; DESULFOVIBRIO VULGARIS; DETOXIFICATION; DIET SUPPLEMENTATION; DISEASE COURSE; ESCHERICHIA COLI; FATTY ACID OXIDATION; HUMAN; INTESTINE CELL; LIPOGENESIS; NITROSATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PSEUDOMONAS AERUGINOSA; REMISSION; REVIEW; TIGHT JUNCTION; TISSUE INJURY; ULCERATIVE COLITIS;

ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; COLITIS, ULCERATIVE; DIET; HUMANS; NITRIC OXIDE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 39849106156     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03612.x     Document Type: Review

References (125)

1. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007 117: 514 21.
2. Lukas M, Bortlik M, Zdenek M. What is the origin of ulcerative colitis? Still more questions than answers. Postgrad Med J 2006 82: 620 5.
3. Baumgart D, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet 2007 369: 1627 40.
4. Sartor RB. Microbial influences in inflammatory bowel diseases: role in pathogenesis and clinical implications. In: Sartor RB, Sandborn WJ, eds. Kirsner's Inflammatory Bowel Disease, 6th edn. Edinburgh: Saunders, 2004: 138 62.
5. Roediger WEW. What sequence of pathogenetic events leads to acute ulcerative colitis? Dis Colon Rectum 1988 31: 482 7.
6. Guarner F, Malagelada J-R. Gut flora in health and disease. Lancet 2003 361: 512 9.
7. Subramanian S, Campbell BJ, Rhodes JM. Bacteria in the pathogenesis of inflammatory bowel disease. Curr Opin Infect Dis 2006 19: 475 84.
8. Tannock GW. New perspectives of the gut microbiota: implications for future research. Gastroenterol Clin N Am 2005 34: 361 82.
9. Blaut M, Clavel T. Metabolic diversity of the intestinal microbiota: implication for health and disease. J Nutr 2007 137: 7515 55.
10. Garner CE, Smith S, Costello B, et al. Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J 2007 21: 1675 88.
11. Madigan MT, Martinko JM, Parker J (eds). Anaerobic respiration. In: Brock Biology of Microorganisms, 10th edn. Upper Saddle River, NJ: Prentice Hall, 2003: 576 9.
12. Stephen AM, Cummings JH. Mechanism of action of dietary fibre in the human colon. Nature 1980 284: 283 4.
13. Nakano MM, Zuber P. Anaerobic growth of a "strict aerobe" (Bacillus subtilis). Annu Rev Microbiol 1998 52: 165 90.
14. Strohm TO, Griffin B, Zumft WG, Schink B. Growth yields in bacterial denitrification and nitrate ammonification. Appl Environ Microbiol 2007 73: 1420 4.
15. Cumming JH, Rombeau JL, Sakata T (eds). Physiological and Clinical Aspects of Short-Chain Fatty Acids. Cambridge: Cambridge University Press, 1995.
16. Prescott LM, Harley JP, Klein DA (eds). Microbiology, 6th edn. Boston, MA: McGraw Hill, 2005.
17. Richardson DJ. Bacterial respiration: a flexible process for a changing environment. Microbiology 2000 146: 551 71.
18. Einsle O, Kroneck PM. Structural basis of denitrification. J Biol Chem 2004 385: 875 83.
19. Allison C, Macfarlane GT. Effect of nitrate on methane production and fermentation by slurries of human faecal bacteria. J Gen Microbiol 1988 134: 1397 405.
20. Stouthamer AH, Van't Riet J, Oltmann IF. Respiration with nitrate as acceptor. In: Knowles CJ, ed. Diversity of Bacterial Respiratory Systems, Vol. II. Boca Raton, FL: CRC Press, 2000: 19 48.
21. Knowles R Denitrification. Microbiol Rev 1982 46: 43 70.
22. Zumft WG. Cell biology and molecular basis of denitrification. Microbiol Mol Biol Rev 1997 61: 533 616.
23. Robertson GP. Denitrification. In: Summer ME, ed. Handbook of Soil Science. Boca Raton, FL: CRC Press, 2000: C181 90.
24. Bakken L, Dorsch P. Nitrous oxide emission and global changes: modelling approaches. In: Bothe H, Ferguson SJ, Newton WE, eds. Biology of the Nitrogen Cycle. Amsterdam, the Netherlands: Elsevier, 2007: 381 96.
25. Davidson EA, Seitzinger S. The enigma of progress in denitrification research. Ecol Appl 2006 16: 2057 63.
26. Ji X, Hollocher TC. Reduction of nitrite to nitric oxide by enteric bacteria. Biochem Biophys Res Commun 1988 157: 106 8.
27. Cutruzzola F, Rinaldo S, Centola F, Brundri M. NO production by Pseudomonas aeruginosa and nitrite reductase. IUBMB Life 2003 55: 617 21.
28. Cutruzzola F. Bacterial nitric oxide synthesis. Biochim Biophys Acta 1999 1411: 231 49.
29. Silaghi-Dumitrescu R, Ng KY, Viswanathan R, Kurtz D. A flavo-diiron protein from Desulfvibrio vulgaris with oxidase and nitric oxide reductase activity. Evidence for an in vivo nitric oxide scavenging function. Biochemistry 2005 44: 3572 9.
30. Reinders CI, Herulf M, Ljung T, et al. Rectal mucosal nitric oxide in differentiation of inflammatory bowel disease and irritable bowel syndrome. Clin Gastroenterol Hepatol 2005 3: 777 83.
31. Sobko T, Norman M, Norin E, Gustafsson LE, Lundberg JO. Birth-related increase in intracolonic hydrogen gas and nitric oxide as indicator of host microbial interactions. Allergy 2005 60: 396 400.
32. St John RT, Hollocher TC. Nitrogen 15 tracer studies on the pathway of denitrification in Pseudomonas aeruginosa. J Biol Chem 1977 252: 212 8.
33. Betlach MR, Tiedje JM. Kinetic explanation for accumulation of nitrite, nitric oxide and nitrous oxide during bacterial denitrification. Appl Environ Microbiol 1981 42: 1074 84.
34. Beijerinck MW, Minkman DCJ. Bildung und Verbrauch von Stickoxydul durch Bakterien. Centrb Bakteriol Abt II 1910 25: 30 63.
35. Najjar VA, Allen MB. Formation of nitrogen, nitrous oxide and nitric oxide by extracts of denitrifying bacteria. J Biol Chem 1954 206: 209 14.
36. Heiss B, Frunzke K, Zumft WG. Formation of the N-N bond from nitric oxide by a membrane-bound cytochrome bc complex of nitrate respiring (denitrifying) Pseudomonas stutzeri. J Bacteriol 1989 171: 3288 97.
37. Sobko T, Reinders CT, Janson E, Norin E, Midtvedt T, Lundberg JO. Gastrointestinal bacteria generate nitric oxide from nitrate and nitrite. Nitric Oxide 2005 13: 272 8.
38. 2O production during denitrifying enzyme activity (DEA) assays. Soil Biol Biochem 2004 36: 513 7.
39. Philippot L, Hallin S. Finding the missing link between diversity and activity using denitrifying bacteria as a model functional community. Curr Opin Microbiol 2005 8: 234 9.
40. Poole RK. Nitric oxide and nitrosative stress tolerance in bacteria. Biochem Soc Trans 2005 33: 176 80.
41. Choi PS, Naal Z, Moore C, et al. Assessing the impact of denitrifier-produced nitric oxide on other bacteria. Appl Environ Microbiol 2006 72: 2200 5.
42. Justino MC, Vicente JB, Teixeira M, Saraiva LM. New genes implicated in the protection of anaerobically grown Escherichia coli against nitric oxide. J Biol Chem 2005 280: 2636 43.
43. Hermandez-Urzva E, Mills CE, White GP, et al. Flavohemoglobin Hmp but not its individual domains, confers protection from respiratory inhibition by nitric oxide in Escherichia coli. J Biol Chem 2003 278: 34975 82.
44. Gardner AM, Helmick RA, Gardner PR. Flavorubredoxin, an inducible catalyst for nitric oxide reduction and detoxification in Escherichia coli. J Biol Chem 2002 277: 8172 7.
45. Wu G, Wainwright LM, Poole RK. Microbial globins. Adv Microb Physiol 2003 47: 255 310.
46. Frey AD, Kallio PT. Nitric oxide detoxification - a new era for bacterial globins in biotechnology? Trends Biotechnol 2005 23: 69 73.
47. Shah V, Lyford G, Gores G, Farrugia G. Nitric oxide in gastrointestinal health and disease. Gastroenterology 2004 126: 903 13.
48. Kolios G, Valatas V, Ward SG. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 2004 113: 427 37.
49. Roediger WEW. Nitric oxide damage to colonocytes in colitis-by- association: remote transfer of nitric oxide to the colon. Digestion 2002 65: 191 5.
50. Wheeler MA, Smith SD, Garcia-Cardeña G, Nathan CF, Weiss RN, Sassa WC. Bacterial infection induces NOS in human neutrophils. J Clin Invest 1997 99: 110 6.
51. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 1995 268: 697 8.
52. Rachmilewitz D, Stamler JS, Karmeli F, et al. Peroxynitrite-induced colitis - a new model of colonic inflammation. Gastroenterology 1993 105: 1681 8.
53. Roediger WEW. Nitric oxide dependent nitrosation of cellular CoA: a proposal for tissue responses. Nitric Oxide Biol Chem 2001 5: 83 7.
54. Tu SI, Byler M, Cavanaugh JR. Nitrite inhibition of acyl transfer by coenzyme A via the formation of an S-nitrosothiol derivative. J Agric Food Chem 1984 32: 1057 60.
55. Roediger WEW, Hems R, Wiggins D, Gibbons GF. Inhibition of hepatocyte lipogenesis by nitric oxide donor: could nitric oxide regulate lipid synthesis? IUBMB Life Sci 2004 56: 35 40.
56. Ellestad-Sayed JJ, Nelson RA, Adson MA, Adson MA, Palmer WM, Soule EH. Pantothenic acid, coenzyme A and human chronic ulcerative and granulomatous colitis. Am J Clin Nutr 1976 29: 1333 8.
57. Zambell KL, Fitch MD, Fleming SE. Acetate and butyrate are the major substrates for de novo lipogenesis in rat colonic epithelial cells. J Nutr 2003 133: 3509 15.
58. Delpre G, Avidor I, Steinherz R, Kadish U, Ben-Bassat M. Ultrastructural abnormalities in endoscopically and histologically normal and involved colon in ulcerative colitis. Am J Gastroenterol 1989 84: 1038 46.
59. Fernandez-Banares F, Esteve-Comas M, Mane J, et al. Changes in mucosal fatty acid profile in inflammatory bowel disease and in experimental colitis: a common response to bowel inflammation. Clin Nutr 1997 16: 177 83.
60. Ehehalt R, Wagenblast J, Erben G, et al. Phosphatidylcholine and lysophatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoelectrospray-tandem mass spectrometry. Scand J Gastroenterol 2004 39: 737 42.
61. Heimerl S, Moehle C, Zahn A, et al. Alterations in intestinal fatty acid metabolism in inflammatory bowel disease. Biochim Biophys Acta 2006 1762: 341 50.
62. Roediger WEW. The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet 1980 ii: 712 5.
63. Chapman MA, Grahn MF, Boyle MA, Hutton M, Rogers J, Williams NS. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 1994 35: 73 76.
64. Wintrobe MM, Follis RH, Alcayaga R, Paulson M, Humphreys S. Pantothenic acid deficiency in swine. Bull Johns Hopkins Hosp 1943 73: 313 40.
65. ++-dependent mechanism. Lipids 2007 42: 211 28.
66. Denhond E, Hiele M, Evenepoel P, Peters M, Ghoos Y, Rutgeerts P. In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis. Gastroenterology 1998 115: 584 90.
67. 13C]-butyrate for breath test in patients with active and quiescent ulcerative colitis. Scand J Gastroenterol 2007 42: 207 14.
68. Nelson RA. Intestinal transport, coenzyme A and colitis in pantothenic acid deficiency. Am J Clin Nutr 1968 21: 495 501.
69. Kameyama J, Narui H, Inui M, Sato T. Energy level in large intestinal mucosa in patients with ulcerative colitis. Tohoku J Exp Med 1984 143: 253 4.
70. Edmonds CJ. Electrical potentials of the sigmoid colon and rectum in irritable bowel syndrome and ulcerative colitis. Gut 1970 11: 867 74.
71. Ramakrishna BS, Roberts-Thomson IC, Pannall PR, Roediger WEW. Impaired sulphation of phenol by the colonic mucosa in quiescent and active ulcerative colitis. Gut 1991 32: 46 9.
72. Ivanov AI, Nusrat A, Parkos CA. The epithelium in inflammatory bowel disease: potential role of endocytosis of junctional proteins in barrier disruption. Novartis Found Symp 2004 263: 115 32.
73. Gibson PR, Van De Poi E, Barratt PJ, Doe WF. Ulcerative colitis - a disease characterised by the abnormal colonic epithelial cell. Gut 1988 29: 516 21.
74. Rhodes JM. Mucins and inflammatory bowel disease. Q J Med 1997 90: 79 82.
75. Finnie IA, Dwarakanath AD, Taylor BA, Rhodes JM. Colonic mucin synthesis is increased by sodium butyrate. Gut 1995 36: 93 9.
76. +-ATPase in ulcerative colitis. J Pathol 2004 204: 84 92.
77. Sandle GI, Perry MD, Mathialahan T, et al. Altered cryptal expression of luminal potassium (BK) channels in ulcerative colitis. J Pathol 2007 212: 66 73.
78. Werner TV. Intestinal epithelial cell (IEC) proteomics under condition of chronic inflammation. Gastroenterology 2007 132: A552.
79. Roediger WEW. Role of anaerobic bacterial in the metabolic welfare of the colonic mucosa. Gut 1980 21: 793 8.
80. Ardawi MS, Newsholme EA. Fuel utilization in colonocytes of the rat. Biochem J 1985 231: 713 9.
81. Ashcroft FM. From molecule to malady. Nature 2006 440: 443 7.
82. Curran RD, Ferrari FK, Kispert PH, et al. Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis. FASEB J 1991 5: 2085 92.
83. Ischiropoulos H, Gow A. Pathophysiological functions of nitric oxide-mediated protein modifications. Toxicology 2005 208: 299 303.
84. Salzman AL, Menconi MJ, Unno N, et al. Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BBe intestinal epithelial monolayers. Am J Physiol 1995 268: G361 73.
85. Roediger WEW, Nance S. Selective reduction of fatty acid oxidation in colonocytes: correlation with ulcerative colitis. Lipids 1990 25: 646 52.
86. Roediger WEW, Duncan A, Kapaniris O, Millard S. Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology 1993 104: 802 9.
87. Santhanam S, Venkatraman A, Ramakrishna BS. Impairment of mitochondrial acetoacetyl CoA thiolase activity in the colonic mucosa of patients with ulcerative colitis. Gut 2007 56: 1543 9.
88. Roediger WEW, Babidge WJ. Nitric oxide effect on colonocyte metabolism: co-action of sulfides and peroxide. Mol Cell Biochem 2000 206: 159 67.
89. Needleman P, Jakschik B, Johnson EM. Sulphydryl requirement for relaxation of vascular smooth muscle. J Pharmacol Exp Ther 1973 187: 324 31.
90. Ignarro LJ, Lippton H, Edwards JU, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981 218: 739 49.
91. Magee EA, Richardson CJ, Hughes R, Cummings JH. Contribution of dietary protein to sulfide production in the large intestine: an in vitro and a controlled feeding study in humans. Am J Clin Nutr 2000 72: 1488 94.
92. Levitt MD, Furne J, Springfield J, Suarez F, DeMaster E. Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa. J Clin Invest 1999 104: 1107 4.
93. Roediger WEW, Duncan A. 5-aminosalicylic acid decreases colonic sulfide formation: implications for ulcerative colitis. Med Sci Res 1996 24: 27 29.
94. Pitcher MCL, Beatty ER, Cummings JH. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to fecal sulphide in patients with ulcerative colitis. Gut 2000 46: 64 72.
95. Gibson GR, Cummings JH, Macfarlane GT. Growth and activities of sulphate-reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis. FEMS Microbiol Ecol 1991 86: 103 12.
96. Jowett SL, Seal CJ, Pearce MS, et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut 2004 53: 1479 84.
97. Roediger WEW, Lawson MJ, Nance SH, Radcliffe BC. Detectable colonic nitrite in inflammatory bowel disease - mucosal or bacterial malfunction? Digestion 1986 35: 199 204.
98. Middleton SJ, Shorthouse M, Hunter JO. Increased nitric oxide synthesis in ulcerative colitis. Lancet 1993 341: 465 6.
99. Lundberg JO, Hellström PM, Lundberg JM, Alving K. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994 344: 1673 4.
100. Herulf M, Ljung T, Hellström PM, Weitzberg E, Lundberg JO. Increased luminal nitric oxide in inflammatory bowel disease as shown with a novel minimally invasive method. Scand J Gastroenterol 1998 33: 164 9.
101. Reinders CI, Jonkers D, Jansson EA, et al. Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease. Scand J Gastroenterol 2007 42: 1151 7.
102. Kruis W, Fric P, Pokrotnieks J, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli is as effective as with standard mesalazine. Gut 2004 53: 1617 23.
103. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007 448: 427 34.
104. Tannock GW. What immunologists should know about bacterial communities of the human bowel. Semin Immunol 2007 19: 94 105.
105. Liu L, Zeng M, Stamler JS. Hemoglobin induction in mouse macrophages. Proc Natl Acad Sci U S A 1999 96: 6643 7.
106. Newton DA, Rao KMK, Dluhy RA, Baatz JE. Hemoglobin is expressed by alveolar epithelial cells. Proc Natl Acad Sci U S A 2006 281: 5668 76.
107. Needleman P, Blehm DJ, Rotskoff KB. Relationship between glutathione-dependent denitration and the vasodilator effectiveness of organic nitrates. J Pharmacol Exp Ther 1969 165: 286 8.
108. Sido B, Hack V, Hochlehnert A, Lipps H, Herfarth C, Droge W. Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease. Gut 1998 42: 485 92.
109. Holmes EW, Yong SL, Eiznhamer D, Keshavarzian A. Glutathione content of colonic mucosa: evidence for oxidative damage in active ulcerative colitis. Dig Dis Sci 1998 43: 1088 95.
110. Savidge TC, Newman P, Pothoulakis C, et al. Enteric glia regulate intestinal barrier function and inflammation via release of S- nitrosoglutathione. Gastroenterology 2007 132: 1344 58.
111. Gibson GR, McCartney AL. Modification of the gut flora by dietary means. Biochem Soc Trans 1998 26: 222 8.
112. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel disease: antibiotics, probiotics and prebiotics. Gastroenterology 2004 126: 1620 33.
113. Burke DA, Axon AT, Clayden SA, Dixon MF, Johnston D, Lacey RW. The efficacy of tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Ther 1990 4: 123 9.
114. Lobo AJ, Burke DA, Sobala GM, Axon AT. Oral tobramycin in ulcerative colitis: effect on maintenance of remission. Aliment Pharmacol Ther 1993 7: 155 8.
115. Guslandi M. Antibiotics for inflammatory bowel disease: do they work? Eur J Gastroenterol Hepatol 2005 17: 145 7.
116. Ohkusa T, Kato K, Terao S, et al. Three-antibiotic combination therapy in patients with active ulcerative colitis: a double-blind placebo-controlled multicentre trial. Gastroenterology 2007 132: A131.
117. Woodmansey EJ, McMurdo MET, Macfarlane GT, Macfarlane S. Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 2004 70: 6113 22.
118. Tuohy KM, Rouzaud GCM, Bruck WM, Gibson GR. Modulation of the human gut microflora towards improved health using pre-biotics - assessment of efficacy. Curr Pharm Des 2005 11: 75 90.
119. Macfarlane S, Macfarlane GT, Cummings JH. Review article: prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther 2006 24: 701 14.
120. Roediger WEW. Decreased sulphur amino acid intake in ulcerative colitis. Lancet 1998 351: 1555.
121. Magee EA, Edmond LM, Tasker S, Kong SC, Curno R, Cummings JH. Associations between diet and disease activity in ulcerative colitis patient using a novel method of data analysis. Nutr J 2005 4: 7 15.
122. Cummings JH, Macfarlane GT, Magee E. The Toxicity of Reduced Sulphur Compounds in the Human Large Intestine: A Novel Approach to Management of Ulcerative Colitis by Dietary Intervention. St Albans: National Association for Colitis and Crohn's Diseases, 2005 (reference code 01/7-2).
123. Sheil B, Shanahan F, O'Mahony L. Probiotic effects on inflammatory bowel disease. J Nutr 2007 137: 819S 24S.
124. Haskey N, Dahl WJ. Synbiotic therapy: a promising new adjunctive therapy for ulcerative colitis. Nutr Rev 2006 64: 132 8.
125. Furrie E, Macfarlane S, Kennedy A, et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 2005 54: 242 9.